• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

It May Be Easier to Quit Smoking With Holistic or Integrated Health Approach

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 14, 2025.

By Dennis Thompson HealthDay Reporter

TUESDAY, Jan. 14, 2025 -- It takes a village to help a smoker quit.

And a new study published recently in JAMA Internal Medicine shows that smokers had a nearly doubled success rate quitting when supported by an integrated approach that included medication and personal counseling.

"Our study demonstrates that providing access to effective medications and trained tobacco cessation specialists offers the greatest chance at successfully quitting and, hopefully, avoiding the potential of lung cancer,” principal investigator Paul Cinciripini, executive director of the University of Texas MD Anderson Cancer Center’s Tobacco Research and Treatment Program, said in a news release from the college.

Lung cancer is the top cancer killer in the U.S., accounting for one in five cancer-related deaths, researchers said in background notes.

Tobacco use is responsible for 85% of lung cancer cases and contributes to nearly 30% of all cancer-related deaths, researchers added.

The average smoker requires several attempts before they’re able to break their nicotine addiction and quit, researchers said.

For this study, researchers recruited a group of 630 smokers between 2017 and 2021. The smokers were at least 50, and smoked an average 20 cigarettes a day.

The smokers were randomly assigned to one of three groups, each containing 210 people.

One group was provided nicotine replacement therapy or medication and access to phone-based support. The second received the same, only prescribed by a lung cancer screening doctor.

The third group received nicotine replacement therapy or medication, but instead of phone support had access to counseling provided by a team of specialists and physicians.

The integrated care group had the highest quit rate after three months, about 37%, compared to 27% in the group prescribed treatment by a lung cancer screening doc and 21% to people with quitline support.

That held true after six months as well -- 32% for integrated care, nearly 28% for the lung cancer screening group, and 20% for the quitline group.

"Facilities equipped to provide dedicated and integrated care should prioritize doing so to offer patients the best opportunity for smoking cessation and improved health outcomes," Cinciripini said.

"Given our results, it is conceivable that this approach could also be highly effective outside a screening environment, such as post-traumatic stress clinics and among patients with cancer, cardiovascular disease or diabetes,” Cinciripini concluded.

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted January 2025

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.